• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

IRA Eliquis slashed in half


<



CV will just not sink. Every division will feel the effects. Eliquis is the main source of income for the company. Layoffs have begun and will persist for the next year. It's certainly time to update your resume and begin your job hunt.